MORGAN STANLEY - ALBIREO PHARMA INC ownership

ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 111 filers reported holding ALBIREO PHARMA INC in Q1 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.3%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of ALBIREO PHARMA INC
ValueSharesWeighting
Q4 2022$3,120,980
+31.1%
144,423
+17.4%
0.00%
Q3 2022$2,381,000
-22.1%
122,993
-20.1%
0.00%
Q2 2022$3,058,000
+88.8%
153,978
+183.6%
0.00%
Q1 2022$1,620,000
+73.1%
54,300
+35.1%
0.00%
Q4 2021$936,000
+56.8%
40,193
+109.9%
0.00%
Q3 2021$597,000
+30.3%
19,145
+47.3%
0.00%
Q2 2021$458,000
+676.3%
12,996
+675.4%
0.00%
Q1 2021$59,000
-89.3%
1,676
-88.6%
0.00%
Q4 2020$552,000
+736.4%
14,724
+642.1%
0.00%
Q3 2020$66,000
-45.5%
1,984
-56.5%
0.00%
Q2 2020$121,000
+426.1%
4,566
+216.4%
0.00%
Q1 2020$23,000
-94.0%
1,443
-90.4%
0.00%
Q4 2019$383,000
+480.3%
15,051
+352.1%
0.00%
Q3 2019$66,000
+312.5%
3,329
+573.9%
0.00%
Q2 2019$16,000
-77.1%
494
-77.1%
0.00%
Q1 2019$70,000
-80.3%
2,157
-85.1%
0.00%
Q4 2018$355,000
-29.3%
14,493
-4.8%
0.00%
Q3 2018$502,000
-28.6%
15,221
-23.2%
0.00%
Q2 2018$703,000
+149.3%
19,810
+128.9%
0.00%
Q1 2018$282,000
+15.6%
8,656
-9.1%
0.00%
Q4 2017$244,000
+2340.0%
9,522
+1983.6%
0.00%
Q3 2017$10,000
-37.5%
457
-49.3%
0.00%
Q4 2016$16,0009020.00%
Other shareholders
ALBIREO PHARMA INC shareholders Q1 2022
NameSharesValueWeighting ↓
Prosight Management, LP 480,000$14,318,0009.25%
Decheng Capital Management III (Cayman), LLC 518,342$15,462,0004.74%
TANG CAPITAL MANAGEMENT LLC 467,702$13,952,0002.79%
Birchview Capital, LP 113,000$3,371,0002.43%
Privium Fund Management B.V. 351,805$10,494,0002.32%
Sio Capital Management, LLC 144,546$4,312,0001.43%
Perceptive Advisors 2,360,139$70,403,0001.41%
Chicago Capital, LLC 1,011,744$30,180,0001.30%
Endurant Capital Management LP 120,834$3,604,0000.95%
Nicholas Investment Partners, LP 439,235$13,102,0000.93%
View complete list of ALBIREO PHARMA INC shareholders